Revalesio

At Revalesio, we are determined to develop a new class of therapeutics to help transform the treatment of acute and chronic neurological disorders. Our team is comprised of passionate individuals from diverse backgrounds who are inspired to innovate. We pride ourselves in fostering a supportive, respectful, and dynamic work environment, in which everyone is encouraged […]

Revalesio is a clinical-stage pharmaceutical company committed to developing treatments for stroke and age-related neurological disorders that lack adequate therapeutic options. Our mission centers on the growing body of scientific evidence that restoring mitochondrial health is the key to cellular resilience. Our therapies specifically address mitochondrial dysfunction and the resulting bioenergetic failure as well as […]

Revalesio is a clinical-stage pharmaceutical company focused on treating the bioenergetic failure that is the root cause of many conditions that impact human health. Our pioneering research targets the mitochondria ― the cellular engine ― addressing foundational metabolic imbalances. These imbalances drive both the acute damage to the brain and the cerebral vascular system post-stroke, […]

Revalesio’s Privacy Policy was last updated in June 2021. Our Policy Our website was created to provide information about our company. This Privacy Policy sets forth Revalesio’s policy with respect to information including personally identifiable data (“Personal Data”) and other information that may be collected from website visitors. Access to and use of our website […]

Revalesio is a clinical-stage pharmaceutical company focused on treating the bioenergetic failure that is the root cause of many conditions that impact human health. Our pioneering research targets the mitochondria ― the cellular engine ― addressing foundational metabolic imbalances. These imbalances drive both the acute damage to the brain and the cerebral vascular system post-stroke, […]